Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - aspirin 500mg - tablet - 500 mg - active: aspirin 500mg excipient: maize starch powdered cellulose

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

bayer limited - praziquantel pyrantel embonate - tablets - 230/20.0 unknown - endoparasiticide - feline

Sérvia - sérvio - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

bayer d.o.o. beograd - oktokog Алфа - prašak i rastvarač za rastvor za injekciju - 1000i.j./2.5ml

Sérvia - sérvio - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

bayer d.o.o. beograd - oktokog Алфа - prašak i rastvarač za rastvor za injekciju - 250i.j./2.5ml

Sérvia - sérvio - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

bayer d.o.o. beograd - oktokog Алфа - prašak i rastvarač za rastvor za injekciju - 500i.j./2.5ml

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 20mg (plus 10% overage) - modified release tablet - 20 mg - active: nifedipine 20mg (plus 10% overage) excipient: cellulose acetate hypromellose   iron oxide red macrogol 3350 magnesium stearate opacode black s-1-17823 opadry pink oy-s-24914 polyethylene oxide sodium chloride - treatment of coronary heart disease

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 33mg (active blend) - modified release tablet - 30 mg - active: nifedipine 33mg (active blend) excipient: cellulose acetate hypromellose   iron oxide red macrogol 3350 magnesium stearate as 0.4mg in active blend, 0.2mg in osmotic blend opacode black s-1-17823 opadry pink oy-s-24914 polyethylene oxide sodium chloride - treatment of coronary heart disease

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 66mg (active blend) - modified release tablet - 60 mg - active: nifedipine 66mg (active blend) excipient: cellulose acetate hypromellose   iron oxide red macrogol 3350 magnesium stearate as 0.8mg in active blend, 0.4mg in osmotic blend opacode black s-1-17823 opadry pink oy-s-24914 polyethylene oxide sodium chloride - -treatment of coronary heart disease -chronic stable angina pectoris (angina of effort) - treatment of hypertension

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 90mg - modified release tablet - 90 mg - active: nifedipine 90mg excipient: cellulose acetate hyprolose hypromellose   iron oxide red   macrogol 3350 magnesium stearate polyethylene oxide propylene glycol sodium chloride titanium dioxide

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

bayer new zealand limited - moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin - film coated tablet - 400 mg - active: moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin excipient: croscarmellose sodium hypromellose iron oxide red lactose monohydrate macrogol 4000 magnesium stearate powdered cellulose titanium dioxide - avelox tablets and solution for infusion is indicated for the treatment of the following bacterial infections caused by susceptible strains: · bronchitis (acute exacerbations of chronic bronchitis)